CCL2 and prostate carcinoma: The Top 5 GO molecular functions for the most influential biomarkers in the ABCD‐prostate cancer oncogenic network (IL‐1β, MCP‐1, and CXCL1) are consistently related to glycosaminoglycan/integrin binding and immune receptor activity (predominantly as IL‐1β function) (Table 3).